Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Farmers Insurance
Queensland Health
Argus Health
Baxter
Citi

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 9,938,331

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,938,331
Title:Biologically active proteins having increased in vivo and/or in vitro stability
Abstract: The present invention provides unstructured recombinant polymers (URPs) and proteins containing one or more of the URPs. The present invention also provides microproteins, toxins and other related proteinaceous entities, as well as genetic packages displaying these entities. The present invention also provides recombinant polypeptides including vectors encoding the subject proteinaceous entities, as well as host cells comprising the vectors. The subject compositions have a variety of utilities including a range of pharmaceutical applications.
Inventor(s): Schellenberger; Volker (Palo Alto, CA), Stemmer; Willem P. (Los Gatos, CA), Wang; Chia-Wei (Santa Clara, CA), Scholle; Michael D. (Mountain View, CA), Gordon; Nathaniel C. (Campbell, CA), Crameri; Andreas (Los Altos Hills, CA), Popkov; Mikhail (San Diego, CA)
Assignee: Amunix Operating Inc. (Mountain View, CA)
Application Number:14/970,723
Patent Claims:see list of patent claims

Details for Patent 9,938,331

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Sign Up Amunix Operating Inc. (Mountain View, CA) 2025-09-27 RX search
Genentech ACTIVASE alteplase VIAL; SINGLE-USE 103172 001 1987-11-13 ➤ Sign Up Amunix Operating Inc. (Mountain View, CA) 2025-09-27 RX search
Genentech ACTIVASE alteplase VIAL; SINGLE-USE 103172 002 1987-11-13 ➤ Sign Up Amunix Operating Inc. (Mountain View, CA) 2025-09-27 RX search
Genentech CATHFLO ACTIVASE alteplase VIAL 103172 003 1987-11-13 ➤ Sign Up Amunix Operating Inc. (Mountain View, CA) 2025-09-27 RX search
Sanofi Synthelabo ELITEK rasburicase VIAL; INTRAVENOUS 103946 001 2002-07-12 ➤ Sign Up Amunix Operating Inc. (Mountain View, CA) 2025-09-27 RX search
Biomarin ALDURAZYME laronidase VIAL 125058 001 2003-04-30 ➤ Sign Up Amunix Operating Inc. (Mountain View, CA) 2025-09-27 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Moodys
Federal Trade Commission
Julphar
QuintilesIMS
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.